Cargando…

Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer

BACKGROUND AND PURPOSE: The criteria for selecting patients who may benefit from surgery of spinal cord compression in metastatic prostate cancer are poorly defined. We therefore studied patients operated for metastatic spinal cord compression in order to evaluate outcome of surgery and to find pred...

Descripción completa

Detalles Bibliográficos
Autores principales: Crnalic, Sead, Hildingsson, Christer, Wikström, Pernilla, Bergh, Anders, Löfvenberg, Richard, Widmark, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278662/
https://www.ncbi.nlm.nih.gov/pubmed/21657974
http://dx.doi.org/10.3109/17453674.2011.590761
_version_ 1782223602198773760
author Crnalic, Sead
Hildingsson, Christer
Wikström, Pernilla
Bergh, Anders
Löfvenberg, Richard
Widmark, Anders
author_facet Crnalic, Sead
Hildingsson, Christer
Wikström, Pernilla
Bergh, Anders
Löfvenberg, Richard
Widmark, Anders
author_sort Crnalic, Sead
collection PubMed
description BACKGROUND AND PURPOSE: The criteria for selecting patients who may benefit from surgery of spinal cord compression in metastatic prostate cancer are poorly defined. We therefore studied patients operated for metastatic spinal cord compression in order to evaluate outcome of surgery and to find predictors of survival. PATIENTS AND METHODS: We reviewed the records of 54 consecutive patients with metastatic prostate cancer who were operated for spinal cord compression at Umeå University Hospital. The indication for surgery was neurological deficit due to spinal cord compression. 41 patients had hormone-refractory cancer and 13 patients had previously untreated, hormone-naïve prostate cancer. 29 patients were operated with posterior decompression only, and in 25 patients posterior decompression and stabilization was performed. RESULTS: Preoperatively, 6/54 of patients were able to walk. 1 month after surgery, 33 patients were walking, 15 were non-ambulatory, and 6 had died. Mortality rate was 11% at 1 month, 41% at 6 months, and 59% at 1 year. In the hormone-naïve group, 8/13 patients were still alive with a median postoperative follow-up of 26 months. In the hormone-refractory group, median survival was 5 months. Patients with hormone-refractory disease and Karnofsky performance status (KPS) of ≤ 60% had median survival of 2.5 months, whereas those with KPS of 70% and KPS of ≥ 80% had a median survival of 7 months and 18 months, respectively (p < 0.001). Visceral metastases were present in 12/41 patients with hormone-refractory tumor at the time of spinal surgery, and their median survival was 4 months—as compared to 10 months in patients without visceral metastases (p = 0.003). Complications within 30 days of surgery occurred in 19/54 patients. INTERPRETATION: Our results indicate that patients with hormone-naive disease, and those with hormone-refractory disease with good performance status and lacking visceral metastases, may be helped by surgery for metastatic spinal cord compression.
format Online
Article
Text
id pubmed-3278662
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Informa Healthcare
record_format MEDLINE/PubMed
spelling pubmed-32786622012-02-15 Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer Crnalic, Sead Hildingsson, Christer Wikström, Pernilla Bergh, Anders Löfvenberg, Richard Widmark, Anders Acta Orthop Article BACKGROUND AND PURPOSE: The criteria for selecting patients who may benefit from surgery of spinal cord compression in metastatic prostate cancer are poorly defined. We therefore studied patients operated for metastatic spinal cord compression in order to evaluate outcome of surgery and to find predictors of survival. PATIENTS AND METHODS: We reviewed the records of 54 consecutive patients with metastatic prostate cancer who were operated for spinal cord compression at Umeå University Hospital. The indication for surgery was neurological deficit due to spinal cord compression. 41 patients had hormone-refractory cancer and 13 patients had previously untreated, hormone-naïve prostate cancer. 29 patients were operated with posterior decompression only, and in 25 patients posterior decompression and stabilization was performed. RESULTS: Preoperatively, 6/54 of patients were able to walk. 1 month after surgery, 33 patients were walking, 15 were non-ambulatory, and 6 had died. Mortality rate was 11% at 1 month, 41% at 6 months, and 59% at 1 year. In the hormone-naïve group, 8/13 patients were still alive with a median postoperative follow-up of 26 months. In the hormone-refractory group, median survival was 5 months. Patients with hormone-refractory disease and Karnofsky performance status (KPS) of ≤ 60% had median survival of 2.5 months, whereas those with KPS of 70% and KPS of ≥ 80% had a median survival of 7 months and 18 months, respectively (p < 0.001). Visceral metastases were present in 12/41 patients with hormone-refractory tumor at the time of spinal surgery, and their median survival was 4 months—as compared to 10 months in patients without visceral metastases (p = 0.003). Complications within 30 days of surgery occurred in 19/54 patients. INTERPRETATION: Our results indicate that patients with hormone-naive disease, and those with hormone-refractory disease with good performance status and lacking visceral metastases, may be helped by surgery for metastatic spinal cord compression. Informa Healthcare 2012-02 2012-02-08 /pmc/articles/PMC3278662/ /pubmed/21657974 http://dx.doi.org/10.3109/17453674.2011.590761 Text en Copyright: © Nordic Orthopaedic Federation http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the source is credited.
spellingShingle Article
Crnalic, Sead
Hildingsson, Christer
Wikström, Pernilla
Bergh, Anders
Löfvenberg, Richard
Widmark, Anders
Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer
title Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer
title_full Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer
title_fullStr Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer
title_full_unstemmed Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer
title_short Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer
title_sort outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278662/
https://www.ncbi.nlm.nih.gov/pubmed/21657974
http://dx.doi.org/10.3109/17453674.2011.590761
work_keys_str_mv AT crnalicsead outcomeaftersurgeryformetastaticspinalcordcompressionin54patientswithprostatecancer
AT hildingssonchrister outcomeaftersurgeryformetastaticspinalcordcompressionin54patientswithprostatecancer
AT wikstrompernilla outcomeaftersurgeryformetastaticspinalcordcompressionin54patientswithprostatecancer
AT berghanders outcomeaftersurgeryformetastaticspinalcordcompressionin54patientswithprostatecancer
AT lofvenbergrichard outcomeaftersurgeryformetastaticspinalcordcompressionin54patientswithprostatecancer
AT widmarkanders outcomeaftersurgeryformetastaticspinalcordcompressionin54patientswithprostatecancer